Written by a multidisciplinary team of experts involved in the development of standards and guidelines for its management in the USA, UK, Europe and Asia, the book contains succinct and knowledgeable summaries of the management of thyroid cancer. Every chapter describes a different aspect of care, and provides clear and detailed information about caring for patients with this group of tumors. This is an invaluable reference to health care professionals, from primary to tertiary care, involved in the management of thyroid cancer such as clinical nurse specialists, clinical psychologists, family medicine practitioners, specialists in palliative care (especially for anaplastic thyroid cancers), geneticists and surgeons, endocrinologists, oncologists, pathologists, and radiologists.

This book provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians and researchers with an interest in the management of thyroid nodules and cancer, including both surgeons and endocrinologists. The book reviews new data about risk factors for nodular disease and cancer, details the management of toxic and non-toxic benign thyroid nodular disease, discusses controversies in the management of indeterminate thyroid nodules and cancer, and reviews the latest data on use of molecular testing for diagnosis and prognosis. Lastly, the book reviews the management of difficult-to-treat thyroid cancers. Management of Thyroid Nodules and Differentiated Thyroid Cancer: A Practical Guide will serve as a useful resource for physicians and researchers dealing with, and interested in thyroid nodular disease and cancer. It will provide a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters are written by experts in their fields and include the most up to date scientific and clinical information.

Leonard Wartofsky, MD, past president of the American Thyroid Association, and a panel of world-class clinicians critically review all aspects of thyroid cancer from pathogenesis to prognosis, including management and treatment. Organized for rapid access by busy physicians, the book covers both differentiated tumors (papillary carcinoma and follicular carcinoma) and undifferentiated cancers (anaplastic carcinoma, lymphoma, and medullary carcinoma), as well as miscellaneous and unusual cancers of the thyroid. For each tumor type the authors succinctly discuss the key aspects of their clinical presentation, cytology, diagnosis, nuclear isotope scanning evaluation, imaging by MRI or CT, monitoring, surgery, pathology, post-operative care, and prognosis. Authoritative and evidenced-based, Thyroid Cancer: A Comprehensive Guide to Clinical Management provides in one place everything that physicians treating thyroid cancer patients need to know.

The goal of this book is to provide Endocrinologists, Surgeons, Nuclear Medicine Physicians, and Radiation Oncologists with practical advice about managing patients with thyroid cancer. This book will not replace the excellent publications that focus on a highly speci?c topic or provide an exhaustive review of major s- jects from the perspective of a particular specialty. These kinds of publications will always be an important source of information for both students and expe- enced practitioners. The void that we see is the lack of a single, concise, up-- date reference that is applicable to all of the specialists who make clinical de- sions about thyroid cancer patients. Essentials of Thyroid Cancer Management will ?ll this void in a manner that is both user-friendly and technically compreh- sive. For reading ef?ciency, this book contains the minimum of text required to explain how to make sound clinical decisions in speci?c situations. We rely heavily on tables, diagrams, graphs, photographs, and other ?gures to convey this information. Subjects are addressed in a large number of chapters that each focus on a relatively narrow topic. In some cases, there is overlap between the information in multiple different chapters so the reader does not have to page back and forth between different sections of the book. As occurs in every area of medicine, there is controversy about important issues in the management of thyroid cancer.

This book covers all aspects of thyroid cancer. Heavily illustrated and including pathology, thyroid and whole-body scans, ultrasounds and other nuclear medicine and radiological studies, the book addresses important issues that physicians should cover when dealing with their patients. The text is designed for physicians, endocrinologists, nuclear medicine physicians, general and head and neck surgeons, oncologists and radiation oncologists, and primary care doctors. Other groups are residents, medical students, and nurse practitioners researching a patient-related problem.

Comprised exclusively of clinical cases covering the diagnosis and treatment of thyroid cancer and related clinical issues, this concise, practical casebook will provide clinicians in endocrinology and oncology with the best real-world strategies to properly manage the various forms of thyroid cancer that they may encounter. Each chapter is a case report, written by recognized experts, that opens with a unique clinical presentation, followed by a description of the diagnosis, assessment and therapy, as well as the case outcome, literature review, clinical pearls and pitfalls, and bibliography. All recommendations are based on evidence-based clinical practice guidelines and recent literature. Cases included illustrate treatment for both low and high risk differentiated thyroid cancer, including surgical approaches, radioiodine therapy, and novel chemotherapies and targeted therapies, as well as postoperative follow-up and special issues. Additional cases demonstrate the management of medullary thyroid cancer, thyroid lymphoma and anaplastic thyroid cancer. Pragmatic and reader-friendly, Thyroid Cancer: A Case-Based Approach will be an excellent resource for clinical endocrinologists and oncologists, endocrine fellows, residents and students alike.

The current age of clinical medicine is witnessing biotechnological innovation at an unprecedented pace. As a result, the recently popularized clinical practice guidelines (CPG), as a tool to assist clinical decision-making, have been struggling to keep up. Thyroid Cancer: From Emergent Biotechnology to Clinical Practice Guidelines rides the wave o